Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common stock, par value $0.00001 · CUSIP: 15117F807
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 2,507,125.00 · Class: 5.73%
- Wilmot B. Harkey
Shares: 2,507,125.00 · Class: 5.73%
- Daniel Mack
Shares: 2,507,125.00 · Class: 5.73%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-014214
- Form type
- SCHEDULE 13G/A
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership